Clinical Trial Update: Etiologic Risk Factors of Cardiovascular Malformations

View source ↗

Summary

The NHLBI-sponsored clinical trial investigating etiologic risk factors for congenital heart defects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Congenital Heart Defects
• Heart Diseases

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Heart Diseases | Status: COMPLETED